Back to List View Graph View

SIRT1

SIRT1 (sirtuin 1) is an NAD(H)-dependent protein deacetylase that functions as a regulator of cellular stress responses, metabolism, chromatin organization, and tissue repair.

Where the papers sit

12 papers from the last 6 months study SIRT1 directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 2 human data · 10 preclinical

Themes 3 themes · 1 new direction

  • Cellular Senescence and Tissue Repair

    Cellular senescence is being connected to defective regeneration, fibrosis, and chronic wound repair. Activating SIRT1 improves endothelial activity and osteogenesis, while USP25–SIRT1 disruption suppresses senescence. SIRT1 also protects diabetic wounds from ferroptosis through the Keap1/Nrf2 pathway. Engineered mesenchymal stem cells extend this strategy toward integrated stress-response control in fibrosis, while heterochromatin regulation links SIRT1 to L1 retrotransposon silencing.

    5 papers · 41.7%

  • Inflammation and Metabolic Stress

    Oxidative stress, inflammatory macrophage dysfunction, and altered glycolysis link these disease studies. Microbiota-derived 4-HPAA stabilizes SIRT1 and reprograms macrophage immunometabolism in Crohn’s disease. FoxO1a–Edil3 impairment worsens transplant-related lung injury, while enavogliflozin reduces oxidative and neuroinflammatory damage in Parkinson’s disease. Transcriptomic work is moving toward disease-dependent glycolysis and lactylation signatures in liver disease.

    4 papers · 33.3%

  • Sirtuin Agonists and Inhibitors

    SIRT1 pharmacology is expanding from natural-product agonists to designed inhibitors and disease-directed pathway modulation. Aspxanthones from Aspergillus provide new agonist candidates, whereas pyrazolyl thioureas are being evaluated against SIRT1 and SIRT2. In diabetic retinopathy, the HIF-1α/PPAR-γ/SIRT1 axis connects astrocyte senescence with endothelial function through GDNF and NRTN. Potency, selectivity, and whether modulation improves vascular outcomes remain the central open questions.

    3 papers · 25%

NEW DIRECTION

SIRT1 is presented as a direct suppressor of LINE-1 retrotransposon activity through heterochromatin maintenance

The cellular-senescence and LINE-1 retrotransposon model assumes SIRT1 mainly functions as a disease-modifying metabolic or stress-response regulator, but this study instead identifies it as a genome-stability factor that binds the LINE-1 5′-UTR and stabilizes Lamin B1/KAP1 heterochromatin complexes, increasing H3K9me3, repressing LINE-1 transcription and delaying senescence. This expands SIRT1’s role to direct transposable-element silencing through chromatin organization 42669067Aug.

Papers

The 12 papers from the last 6 months that study SIRT1 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Cellular Senescence and Tissue Repair (5)
  1. A Novel Peptide Targeting the USP25-SIRT1 Interaction Activates SIRT1 to Suppress Cell Senescence. Aging cell · 30 Oct 2026 PMID 42963318
  2. SIRT1 promotes endothelial activity and osteogenesis in vitro and ameliorates age-related skeletal regeneration defects in vivo. Stem cell reports · 3 Sept 2026 PMID 42692013
  3. Sesamin Promotes Diabetic Wound Healing by Inhibiting Ferroptosis via the SIRT1/Keap1/Nrf2 Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 31 Aug 2026 PMID 42671318
  4. SIRT1 Silences L1 Retrotransposons by Stabilizing Heterochromatin-Modifying Complexes. Aging cell · 30 Aug 2026 PMID 42669067
  5. Engineered mesenchymal stem cells regulate integrated stress response for fibrosis therapy. Med (New York, N.Y.) · 12 Aug 2026 PMID 42586072
Inflammation and Metabolic Stress (4)
  1. Multi-cohort and single-nucleus transcriptomics identify a five-gene lactylation-related panel and a disease-dependent hepatocyte glycolysis-lactylation-related expression program in metabolic dysfunction-associated steatohepatitis. Functional & integrative genomics · 29 Oct 2026 PMID 42955459
  2. Microbiota-derived 4-HPAA alleviates Crohn's disease by stabilizing SIRT1 and reprogramming macrophage immunometabolism. Apoptosis : an international journal on programmed cell death · 23 Aug 2026 PMID 42634048
  3. FoxO1a-mediated Edil3 transcription is impaired in macrophages and exacerbates lung injury after liver transplantation in the aged microenvironment. Molecular immunology · 28 Jul 2026 PMID 42520358
  4. Enavogliflozin alleviates motor deficits in rotenone-induced Parkinson's disease mice via attenuation of oxidative stress and neuroinflammation as well as activation of the SIRT1/PINK1/Parkin pathway. Neuropharmacology · 15 Jul 2026 PMID 42457123
Sirtuin Agonists and Inhibitors (3)
  1. HIF-1α/PPAR-γ/SIRT1 axis drives astrocyte senescence and regulates endothelial function via GDNF/NRTN in diabetic retinopathy. PloS one · 6 Nov 2026 PMID 42993772
  2. Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors. ChemMedChem · 23 Sept 2026 PMID 42778514
  3. Discovery of Aspxanthones A-I with SIRT1 agonist activity from Aspergillus sp. TJ507. Bioorganic chemistry · 18 Aug 2026 PMID 42612273

By study type

Human data, design not indexed (2)
  1. Multi-cohort and single-nucleus transcriptomics identify a five-gene lactylation-related panel and a disease-dependent hepatocyte glycolysis-lactylation-related expression program in metabolic dysfunction-associated steatohepatitis. Functional & integrative genomics · 29 Oct 2026 PMID 42955459
  2. Discovery of Aspxanthones A-I with SIRT1 agonist activity from Aspergillus sp. TJ507. Bioorganic chemistry · 18 Aug 2026 PMID 42612273
Preclinical: animal, cell and lab studies (10)
  1. HIF-1α/PPAR-γ/SIRT1 axis drives astrocyte senescence and regulates endothelial function via GDNF/NRTN in diabetic retinopathy. PloS one · 6 Nov 2026 PMID 42993772
  2. A Novel Peptide Targeting the USP25-SIRT1 Interaction Activates SIRT1 to Suppress Cell Senescence. Aging cell · 30 Oct 2026 PMID 42963318
  3. Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors. ChemMedChem · 23 Sept 2026 PMID 42778514
  4. SIRT1 promotes endothelial activity and osteogenesis in vitro and ameliorates age-related skeletal regeneration defects in vivo. Stem cell reports · 3 Sept 2026 PMID 42692013
  5. Sesamin Promotes Diabetic Wound Healing by Inhibiting Ferroptosis via the SIRT1/Keap1/Nrf2 Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 31 Aug 2026 PMID 42671318
  6. SIRT1 Silences L1 Retrotransposons by Stabilizing Heterochromatin-Modifying Complexes. Aging cell · 30 Aug 2026 PMID 42669067
  7. Microbiota-derived 4-HPAA alleviates Crohn's disease by stabilizing SIRT1 and reprogramming macrophage immunometabolism. Apoptosis : an international journal on programmed cell death · 23 Aug 2026 PMID 42634048
  8. Engineered mesenchymal stem cells regulate integrated stress response for fibrosis therapy. Med (New York, N.Y.) · 12 Aug 2026 PMID 42586072
  9. FoxO1a-mediated Edil3 transcription is impaired in macrophages and exacerbates lung injury after liver transplantation in the aged microenvironment. Molecular immunology · 28 Jul 2026 PMID 42520358
  10. Enavogliflozin alleviates motor deficits in rotenone-induced Parkinson's disease mice via attenuation of oxidative stress and neuroinflammation as well as activation of the SIRT1/PINK1/Parkin pathway. Neuropharmacology · 15 Jul 2026 PMID 42457123